While no statistical difference was observed between the cisplatin and JLSJ groups in relation to the aforementioned indices, the JLSJ group showed a trend toward superior tumor growth control.
← all excerpts
Elucidation of the anti-lung cancer mechanism of Juan-Liu-San-Jie prescription based on network pharmacology and experimental validation.
1
—
—